1. Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia 2. Faculty of Pharmacy, Takasaki University of Health and Welfare, Gunma, Japan 3. School of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan
Inhibition of the apical sodium-dependent bile acid transporter (ASBT, also known as IBAT — ileal bile acid transporter, SLC10A2) leads to disruption of the enterohepatic circulation of bile acids and their excretion with fecal masses. This is accompanied by cholesterol utilization for synthesis of new bile acids. ASBT inhibitors are promising drugs for the treatment of such diseases as non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, type 2 diabetes mellitus, necrotic enterocolitis, chronic constipation, atherosclerosis. To date the most known chemically synthesized inhibitors are: A3309, SHP626, A4250, 264W94, GSK2330672, SC-435. All of them are at different stages of clinical trials, which confirm the high efficacy and good tolerance of these inhibitors. Current trends in this field also include directed chemical synthesis of ASBT inhibitors, as well as their search among substances of plant origin.
Saveleva E.E., Tyutrina E.S., Nakanishi T., Tamai I., Salmina A.B. (2020) The inhibitors of the apical sodium-dependent bile acid transporter (ASBT) as promising drugs. Biomeditsinskaya Khimiya, 66(3), 185-195.
Saveleva E.E. et al. The inhibitors of the apical sodium-dependent bile acid transporter (ASBT) as promising drugs // Biomeditsinskaya Khimiya. - 2020. - V. 66. -N 3. - P. 185-195.
Saveleva E.E. et al., "The inhibitors of the apical sodium-dependent bile acid transporter (ASBT) as promising drugs." Biomeditsinskaya Khimiya 66.3 (2020): 185-195.
Saveleva, E. E., Tyutrina, E. S., Nakanishi, T., Tamai, I., Salmina, A. B. (2020). The inhibitors of the apical sodium-dependent bile acid transporter (ASBT) as promising drugs. Biomeditsinskaya Khimiya, 66(3), 185-195.
Chen L., Yao X., Young A., McNulty J., Anderson D., Liu Y., Nystrom C., Croom D., Ross S. (2012) Am. J. Physiol. Endocrinol. Metab., 302, 68-76. CrossRef Scholar google search
Tiessen R.G., Kennedy C.A., Keller B.T., Levin N., Acevedo L., Gedulin B., Vliet A.A., Dorenbaum A., Palmer M. (2018) BMC Gastroenterology, 18(1), 3. CrossRef Scholar google search
Baghdasaryan A., Fuchs1 C.D., Österreicher C.H., Lemberger U.J., Halilbasic E., Påhlman I., Graffner H., Krones E., Fickert P., Wahlström A., Ståhlman M., Paumgartner G., Marschall H.-U., Trauner M. (2016) J. Hepatol., 64, 674-681. CrossRef Scholar google search
Liu H.-T., He H.-W., Bai X.-G., Wang J.-X., Xu C.-L., Cai S.-Y., Shao R.-G., Wang Y.-C. (2013) Molecules, 18, 6883-6897. CrossRef Scholar google search
Liu H., Pang G., Ren J., Zhao Y., Wang J. (2017) Acta Pharmaceutica Sinica B., 7(2), 223-229. CrossRef Scholar google search
Root C., Smith C.D., Sundseth S.S., Pink H.M., Wilson J.G., Lewis M.C. (2002) J. Lipid Res., 43(8), 1320-1323. CrossRef Scholar google search
Bhat B.G., Rapp S.R., Beaudry J.A., Napawan N., Butteiger D.N., Hall K.A., Null C.L., Luo Y., Keller B.T. (2003) J. Lipid Res., 44(9), 1614-1621. CrossRef Scholar google search
Kramer W., Stengelin S., Baringhaus K.H., Enhsen A., Heuer H., Becker W., Corsiero D., Girbig F., Noll R., Weyland C. (1999) J. Lipid Res., 40(9), 1604-1617. Scholar google search
